Workflow
人工智能多模态脑机接口平台系统
icon
Search documents
从实验室到门诊室 脑机接口产业驶入“快车道”
Core Insights - The establishment of the first brain-computer interface (BCI) outpatient clinic in Central China marks a significant step in the development of BCI technology, providing assessment and treatment consultations for patients nationwide [1] - The BCI industry is experiencing rapid growth driven by favorable policies and technological breakthroughs, with 2023 being a pivotal year for transitioning from research to clinical applications [1][2] - The global market for BCIs in the medical field is projected to reach $40 billion by 2030 and exceed $145 billion by 2040, with China's market expected to grow from 3.2 billion yuan in 2024 to over 5.5 billion yuan by 2027, maintaining an annual growth rate of around 20% [3] Policy Developments - The establishment of a BCI standardization technical committee by the Ministry of Industry and Information Technology aims to develop industry standards across various domains, including ethics and safety [2] - The National Healthcare Security Administration has introduced guidelines for pricing BCI services, paving the way for clinical applications [2] - Local governments are actively promoting BCI industry cultivation plans, with Beijing and Shanghai aiming to become global leaders in BCI technology and applications by 2030 [2] Clinical Applications - BCI technology is rapidly advancing from laboratory research to clinical applications, with several hospitals already implementing BCI systems [4] - Shanghai's Shuli Intelligent Technology has reported its AI multimodal BCI platform entering clinical use in multiple top-tier hospitals [4] - The first long-term implantation clinical trial of an invasive BCI system was completed at Fudan University, with plans for market launch by 2028 [4] Corporate Strategies - Companies are increasingly investing in BCI applications, with Sanbo Neuroscience collaborating with research institutions to bridge innovation and clinical application [5] - Cheng Yi Tong is pursuing a dual-track strategy for invasive and non-invasive BCI technologies, positioning BCI as a key growth area [5] - Yike De is working on a collaborative project to develop an implantable speech synthesis BCI product aimed at helping patients with speech impairments [5] Industry Challenges - Experts highlight several key challenges to large-scale BCI commercialization, including technical standardization, ethical concerns, and the need for interdisciplinary talent [6] - Issues such as biocompatibility, signal interference, and the lack of unified standards hinder the scalability of BCI devices [6] - The high costs of invasive systems and limited insurance coverage pose significant barriers to market entry [6] Recommendations - It is suggested to accelerate the establishment of a technology, standards, and regulatory framework for BCIs, along with exploring diverse payment models for clinical applications [7] - Enhancing collaboration between industry and academia is crucial for developing interdisciplinary talent and reducing redundant efforts in BCI research [7]